Details for 2019167626

Up to date per 26.04.2026

Actions

Title / Product Name

KRISTALLINE FORMEN VON (2R,5S,13AR)-8-HYDROXY-7,9-DIOXO-N-(2,4,6-TRIFLUORBENZYL)-2,3,4,5,7,9,13,13A-OCTAHYDRO-2,5-METHANOPYRIDO[1',2':4,5]PYRAZINO[2,1-B][1,3]OXAZEPIN-10-CARBOXAMID

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2019167626

EP Publication Number

3564244

E-Number

1611226

Language

PCT Number

Publication Date

06.11.2019 A

13.09.2023 B1

Registration Date

13.09.2023

AT Publication Date

15.10.2023

Application Date

19.06.2015

Registration Number

Priorities

20.06.2014

201462015238 P

25.06.2014

201462017183 P

IPC

C07D 498/14 20060101AFI20190715BHEP

Maximum Duration of Protection

19.06.2035

Owner

Gilead Sciences, Inc.333 Lakeside Drive Foster City, CA 94404US

Representative

No representatives present

Inventor

CARRA, Ernest A.c/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA 94404US

CHEN, Irenec/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA 94404US

KEATON, Katie Annc/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA 94404US

ZIA, Vahidc/o Gilead Sciences Inc. 333 Lakeside Drive Foster City, CA 94404US